2009
DOI: 10.1007/s00259-009-1081-5
|View full text |Cite
|
Sign up to set email alerts
|

Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: Comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT

Abstract: Integrated PET/contrast-enhanced CT is an accurate modality for assessing colorectal cancer recurrence and led to changes in the subsequent appropriate therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
33
0
5

Year Published

2009
2009
2024
2024

Publication Types

Select...
4
4
1

Relationship

1
8

Authors

Journals

citations
Cited by 56 publications
(40 citation statements)
references
References 26 publications
2
33
0
5
Order By: Relevance
“…These data are further confirmed by Kitajima and colleagues in a series of studies in patients with uterine, ovarian, colorectal and pancreas cancer [8][9][10][11][12][13].…”
Section: Contrast-enhanced Studies With Pet/ct Hybrid Camerassupporting
confidence: 66%
“…These data are further confirmed by Kitajima and colleagues in a series of studies in patients with uterine, ovarian, colorectal and pancreas cancer [8][9][10][11][12][13].…”
Section: Contrast-enhanced Studies With Pet/ct Hybrid Camerassupporting
confidence: 66%
“…Although improved diagnostic performance of this application was reported in the clinical management of other malignancies [35], the clinical usefulness for breast cancer has not been established and further studies are necessary. In conclusion, FDG-PET/CT has poor sensitivity and high specificity in the detection of axillary lymph node metastasis of breast cancer.…”
Section: Discussionmentioning
confidence: 99%
“…The CT images from the PET/CT scans were not iodine contrast injected. The injection of the iodine product may have offered better identification, as demonstrated by Kitajima et al [25].…”
Section: Discussionmentioning
confidence: 97%
“…Previous series have included between 23 [12] and 107 [18] patients with 5 [12] to 40 [14] PC, but not all PC were of colorectal origin, possibly associated with various FDG uptake. The PET/CT method for CRC has been evaluated in larger series [19][20][21][22][23][24][25] but without a focus on PC. The prevalence of PC in our centre which is a regional reference centre for relapse cancer was 24% (35/146 patients).…”
Section: Discussionmentioning
confidence: 99%